Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04479514 · ClinicalTrials.gov registry record · Phase 2
Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy
A Phase 2 study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT04479514: Completed Phase 2 study, sponsored by Dana-Farber Cancer Institute.
NCT04479514 is a Phase 2 study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 14 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04479514, a Phase 2 study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This research study is examining a preventive skin care regimen for children diagnosed with a brain tumor and receiving anti-cancer therapy with a MEK, Pan-RAF, or BRAF inhibitor.
Primary Outcome
Proportion (percentage) of patients with one or more cutaneous reaction to targeted BRAF, MEK, or Pan-RAF inhibitor therapy
Interventions
- OTHER Moisturizer
- OTHER Warm Baths or Showers
- DRUG SPF 30 or Higher Suncreen
- OTHER Sun Protective Clothing
- BEHAVIORAL Limited Sun Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2025-02-15 |
| Phase | Phase 2 |
What the finished NCT04479514 record still lists
NCT04479514 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 5 interventions - of which Moisturizer is the first listed.
NCT04479514 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04479514 about?
NCT04479514 is a clinical study titled "Preventative Skin Care for Children Undergoing Targeted CNS Tumor Therapy". This research study is examining a preventive skin care regimen for children diagnosed with a brain tumor and receiving anti-cancer therapy with a MEK, Pan-RAF, or BRAF inhibitor.
What is the current status of trial NCT04479514?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2020-10-01. Estimated completion is 2025-02-15.
What interventions are being tested in trial NCT04479514?
The interventions under investigation include: Moisturizer (OTHER), Warm Baths or Showers (OTHER), SPF 30 or Higher Suncreen (DRUG), Sun Protective Clothing (OTHER), Limited Sun Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04479514?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04479514's enrollment target sits among peer trials
14 1941st of 2000 higher than 54 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy